Voce Capital: ConMed Corporation Board Refuses Voce Offer To Settle Proxy Contest

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN FRANCISCO--(BUSINESS WIRE)--Voce Capital Management LLC (“Voce”) made the following statement today relating to the pending proxy contest with CONMED Corporation (“ConMed” or the “Company”) (Nasdaq:CNMD):

In the interest of constructive compromise, yesterday Voce offered to withdraw its proxy solicitation if the Board would appoint two of Voce’s independent nominees to the Board: James W. Green, the President and CEO, and a director, of Analogic (Nasdaq:ALOG) and Joshua H. Levine, the President and CEO, and a director, of Accuray (Nasdaq:ARAY). Neither Mr. Green nor Mr. Levine has any ties or affiliations with Voce and both are outstanding, highly experienced CEOs of publicly-traded medical device companies. Yet the Board wouldn’t even respond to Voce’s proposal.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC